Home/Filings/4/0001437749-19-013452
4//SEC Filing

Nuhaily Dean 4

Accession 0001437749-19-013452

CIK 0001411879other

Filed

Jul 2, 8:00 PM ET

Accepted

Jul 3, 11:58 AM ET

Size

5.5 KB

Accession

0001437749-19-013452

Insider Transaction Report

Form 4
Period: 2019-07-01
Nuhaily Dean
Director
Transactions
  • Award

    Restricted Stock Units

    2019-07-01$1.52/sh+3,948$6,0019,727 total
    From: 2019-07-01Exp: 2029-07-01Common Stock (3,948 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents the contingent right to receive, at settlement, one share of common stock.
  • [F2]The Reporting Person was granted a Restricted Stock Unit on July 1, 2019 of 3,948 shares, which were fully vested on the date of the grant. The RSU is for the Reporting Person's quarterly compensation as a member of the Board of Directors for the second quarter of 2019 and was valued on June 28, 2019 in accordance with the approved compensation plan for the non-employee members of the Board of Directors.
  • [F3]These restricted stock units were granted pursuant to the Issuer's Amended and Restated 2016 Equity Incentive Plan.

Issuer

INNOVUS PHARMACEUTICALS, INC.

CIK 0001411879

Entity typeother

Related Parties

1
  • filerCIK 0001751751

Filing Metadata

Form type
4
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 11:58 AM ET
Size
5.5 KB